ChromaDex founder takes helm at Ginkgo Bioworks spinout


Just under a year after launching, a 'nutraceuticals' startup spun out of Ginkgo Bioworks Holdings Inc. has its first CEO.

Previous Proposal to expand Ascension Seton hospital off 38th St. hits opposition
Next Meet the founder of Petfolk, a new vet clinic that's raised $40 million